TOP NEWS: GSK hails vaccine success for severe virus in older people
(Alliance News) - GSK PLC on Thursday announced a vast decline in severe respiratory syncytial virus, or RSV, disease among people aged 60 years and older who were vaccinated with its RSV vaccine candidate. Read More